Dr. Raghda E. Eldesouki, MD, MSc, PhD, DipIBMed, is a medical geneticist and Assistant Professor specializing in precision medicine, genomics, and multi-omics research . She holds a Bachelor of Medicine (MB.B.Ch), a Master’s degree, and a PhD in Human/Medical Genetics from Suez Canal University, and has undertaken advanced academic and research training at institutions including Johns Hopkins Medicine and Tulane University School of Medicine. She also holds a diploma in business management and additional certifications in medical education and quality assurance.
With over 16 years of experience, her work spans clinical genomics, human genetics, and translational research, with a strong focus on variant selection, genotyping, interpretation, and clinically anchored reporting. She has led and contributed to projects involving whole genome sequencing, genomic surveillance, and integration of genetic data with clinical variables to generate actionable clinical and public health insights. Her technical expertise includes high-throughput screening, assay development, molecular diagnostics, and multi-omics data analysis, alongside the application of machine learning models in translational genomics.
Dr. Eldesouki has contributed to cancer genomics and biomarker discovery, including the development of predictive models and gene expression analyses, and has participated in clinically oriented research involving infectious diseases, immunology, and hematologic malignancies. Her work includes publications in peer-reviewed journals, patent contributions in bi-specific antibody development, and active roles as a peer reviewer for leading international journals such as Scientific Reports, BMC Pediatrics, and the Journal of Medical Virology.
In addition to her research, she has held leadership and administrative roles, including Assistant Director of Quality Assurance, contributing to institutional development, medical education, and research governance. She has also served as Director of Medical Genomics (voluntary) with the American Board of Precision Medicine, supporting initiatives in medical education, communication, and assessment design.
As Scientific Lead – Genetics & Precision Medicine at Amyloidosis Africa, Dr. Eldesouki leads the integration of genomic and precision medicine approaches into the initiative, supporting genetic awareness, variant interpretation frameworks, and the development of research strategies aligned with hereditary and underdiagnosed conditions such as cardiac amyloidosis. Her role focuses on bridging advanced genomic science with real-world clinical application across diverse African healthcare settings.
